To test the possible involvement of platelet-derived growth factor B-chain (PDGF-B) in anterograde and retrograde degenerations of the CNS neurons, we studied the changes of PDGF-B localization and its mRNA expression in the rat retina and optic nerve (ON) after unilateral ON transection, using immunohistochemistry and in situ hybridization. In the control retinas immunoreactivity for PDGF-B and its mRNA expression were localized in the retinal ganglion cells (RGCs) and the nerve fiber layer. After ON transection PDGF-B immunoreactivity in the nerve fiber layer started to decrease on post-injury day 3 or 4. Atrophic changes in the RGCs started on day 5 just after the decrease of PDGF expression, and thereafter the RGC number decreased. In the longitudinal section of the ON rostral to the transected site, swollen axons showed intense PDGF-B immunoreactivity and macrophages, and some glial cells revealed a significant increase in both immunoreactivity and hybridization signals. Based on these findings, we hypothesized that the decrease in PDGF-B in RGCs after axotomy causes the loss of RGCs, and that increased PDGF-B expression in the ON plays a role in the cascade of tissue reactions following ON transection.
Introduction
After complete transection the optic nerve (ON) does not regenerate spontaneously in adult mammals. Two situations appear to underlay the inability of ON regeneration. The first is a marked loss of RGCs after axonal injury, due to retrograde degeneration [1 -3] [4, 5] . The second problem is that the axotomized RGCs fail to extend their axons from the transected site [6 -8] . With a peripheral nerve graft, however, some RGCs survive and extend their axons through the graft [9, 10] . Nevertheless, the peripheral nerve graft itself is not enough to allow all RGCs to regenerate their axons. On the other hand, various growth factors and growth inhibitory factors are known to be involved in tissue responses to ON injury [11] [12] [13] . More information about the role of the factors involved in the responses to ON transection is required to help find a way to regenerate the ON.
Platelet-derived growth factor (PDGF) (a homodimer of PDGF-A or PDGF-B, or an AB heterodimer) is a growth-regulatory molecule and first reported as a chemoattractant for mesenchymal and glial cells [14, 15] . The different PDGF isoforms bind to two receptor types (PDGF h-and i-receptors) with different affinities and induce complex and diverse functions [16, 17] . From our previous studies using monoclonal antibody to PDGF-B, we found its widespread distribution in brain neurons [18, 19] and suggested a novel role of PDGF-B as a neurotrophic factor and/or neuronal regulatory agent. Furthermore, brain neurons have been reported to possess functional PDGF i-receptors [20] which specifically bind to PDGF-B, but have no appreciable affinity for PDGF-A [17] . In the retina Campochiaro et al. [21] were the first to show that both PDGF-B and its specific i-receptors are expressed in cultured retinal pigment epithelial cells and suggested that PDGF-B acts as an autocrine mitogen for these cells. In addition, a previous immunohistochemical study demonstrated increased expression of PDGF Achain and i-receptors in human retinal tissue with proliferative retinopathy [22] . These in vivo and in vitro studies suggest that PDGF-B has some growth regulating function in the retina which also takes part in the anterograde and retrograde changes of the retina after ON transection. However, there has been no study on how PDGF-B immunoreactivity and its mRNA expression are localized in the retina and ON, or their possible modification after ON transection. Thus, in the present study, we first investigated the localization of PDGF-B expression in the retina and ON in intact rats, and then the changes in PDGF-B expression in the protein and mRNA levels during the process of anterograde and retrograde degeneration following ON transection.
Methods
Experiments were performed on 40 male SpragueDawley rats, aged 12 -15 weeks. The animals were anesthetized with sodium pentobarbital. Body temperature was maintained at 37.59 0.5°C with a rectal thermistor connected to a heating lamp. After longitudinal incision of the meningeal sheath, the ON was completely transected unilaterably about 1 mm behind the eyeball [23] . Care was taken to avoid damage to the retinal blood supply. The sham operation followed the same procedures with the exception of transection of the ON. On post-operative days 1, 2, 3, 4, 5, 7, 10, 14 (n = 5 for each), both eye balls and ONs were removed after perfusion with cold phosphate-buffered saline (PBS). The day of the operation was defined as day zero.
After the cornea, iris and lens were removed, retinas with sclera and choroid were fixed overnight in methyl Carnoy's solution at 4°C. The ONs were fixed in the same fixative for 2 h. The sham operated animals were treated using the same procedures. The tissues were embedded in paraffin, and 4 mm thick longitudinal sections were prepared. For the general histological examination, hematoxylin-eosin staining was applied. PDGF-B expression was studied by immunohistochemistry and in situ hybridization histochemistry. Ricinus communis agglumin-120 (RCA-1) staining and glial fibrillary acidic protein (GFAP) immunostaining were performed to identify microglial cells or macrophages and astrocytes, respectively [24] . Tissues subjected to the sham operation were used as controls.
Immunohistochemistry
We analyzed PDGF-B protein expression by immunohistochemistry using the streptavidin-biotin immunoperoxidase method [25] . The primary antibody was mouse monoclonal antibody, PGF-007 (Mochida, Tokyo, Japan), which recognizes both PDGF BB and AB, but not AA [25] . After deparaffinization, endogenous peroxidase activity was blocked with 0.3% H 2 O 2 , with 1% sodium azide (Nakarai tesque, Kyoto, Japan). After being incubated in normal rabbit serum, sections were incubated with the primary antibody (0.2 mg/ml) at 4°C overnight. Additional washes in PBS were followed by an application of biotinylated rabbit antimouse IgG 1 (Zymed Laboratories, San Francisco, CA) at a dilution of 1:400 for 40 min. After washing in PBS, horseradish peroxidase-conjugated streptavidin (Jackson Immunoresearch Laboratories, West Grove, PA) was applied to the sections at a 1:5000 dilution for 40 min. The slides were visualized using 3,3%-diaminobenzidine (DAKO, Kyoto, Japan) with nickel anmonium sulfate in 0.05 M Tris-buffer, pH 7.5, containing H 2 O 2 . Sections were counterstained with methyl green (Sigma, St. Louis, MO).
To test the specificity of the immunostaining, the primary antibody was replaced with non-immune mouse IgG of an equivalent concentration, or PGF-007 preincubated with a 5-M excess of synthetic PDGF-B peptide, and the same procedure was followed (data not shown).
To identify macrophages and microglial cells, lectin histochemistry was performed using RCA-1 (Seikagaku, Tokyo, Japan), which binds specifically to brain macrophages derived from both peripheral blood monocytes and microglial cells [24] . After deparaffinization, endogenous peroxidase activity was blocked by incubating the slides with 0.3% H 2 O 2 in methanol for 20 min. After PBS washes, incubation with RCA-1 was performed at 4°C overnight. The slides were developed using 3,3%-diaminobenzidine as described above. Sections were counterstained with methyl green.
Immunohistochemical staining for GFAP was carried out using a rabbit polyclonal antibody against GFAP (DAKO; diluted 1:600). Immunoreaction was visualized by the streptavidin-biotin immunoperoxidase method using a histofine SAB-PO (R) kit following the manufacturer's instructions (Nichirei, Tokyo, Japan).
To identify the cell specificity of PDGF-B immunoreactivity in the distal portion of ON, immunostaining for PDGF-B and GFAP, and lectin histochemistry for RCA-1 were performed using a series of 1.5 mm thick serial sections of ON from the animals on day 7. 
in situ hybridization
PDGF-B mRNA expression was determined by in situ hybridization histochemistry following the procedures reported by Sasahara et al. [26] .
Probe preparation
A 287-bp fragment of human PDGF-B cDNA spanning the non-coding 3% region was subcloned into plasmid vectors, and then run off incorporation of digoxigenin-labeled UTP was performed to generate labeled antisense-and sense-cRNA probes with T7 RNA polymerase using a T7/Sp6 RNA labeling kit (Boehringer-Mannheim, Germany). Using this digoxigenin-labeled antisense cRNA probe, and our northern blot procedure, we specifically detected transcripts for PDGF-B in RNA isolated from the rat brain [26] .
Hybridization
Tissues were deparaffinized, hydrated and post-fixed with 2% paraformaldehyde for 5 min. They were then treated with 20 mg/ml proteinase K (Gibco BRL, NY) for 5 min at 37°C followed by 2% paraformaldehyde fixation for 5 min. Then sections were incubated with prehybridization solution (60% formamide, Nakarai tesque, Kyoto, Japan), 2× standard sodium citrate (SSC) with 0.5 mg/ml sonicated salmon sperm DNA (Pharmacia, Uppsala, Sweden), 0.5 mg/ml yeast tRNA (Sigma), 0.5 mg/ml heparin, and 1 × Denhalt's solution, for 30 min. Subsequently sections were hybridized overnight with 0.5 mg/ml digoxigenin-labeled cRNA 
Results

Retina
In the normal and sham operation retina, various sizes of neurons were observed in the RGC layer (Fig.  1a) . The larger neurons in this layer showed moderately strong PDGF-B immunoreactivity in their soma (Fig.  1b) . PDGF-B immunoreactivity was also observed in the horizontal cells and a small population of the bipolar cells of the inner nuclear layer, but not in the neurons of the outer nuclear layer, the outer and inner plexiform layers, or the pigment epithelial cells. The most intense PDGF-B immunoreactivity was observed in the axons of the retinal nerve fiber layer. Expression of PDGF-B mRNA was observed in the larger neurons in the RGC layer and in some neurons of the inner nuclear layer, but not in the nerve fiber layer nor in other tissues (Fig. 1c) .
In the retina of the transected side, the larger neurons in the RGC layer began to show atrophic change from day 5 and decreased in number from day 7 to 14 ( Fig.  1d) , whereafter only smaller sized neurons remained. The number of neuronal cells in the RGC layer per photo of each high power microscopic view ( ×400) were counted at the closest proximity to the optic nerve. A total of five HE stained sections from each real and sham-operation animal were prepared 10 and 14 days (n = 5) after operation, and their mean values and standard deviations were compared. There were a total of 38.49 6.6 neurons found in the sham-controls; among the transected animals, the number decreased to 14.7 93.0 (38.2% of the sham-control) on day 10, and to 10.2 9 2.5 (26.5% of the sham-control) on day 14 after the transection. PDGF-B immunoreactivity in the nerve fiber layer decreased markedly from day 5, and on day 14 the nerve fibers showed only very faint staining (Fig. 1e) . The RGCs showed decreased immunoreactivity for PDGF-B from day 4, and also a decrease in cell number after day 7. Only a few ganglion cells retained weak immunoreactivity on day 14, whereas the PDGF-B immunostaining of neurons in the inner nuclear layer was preserved. PDGF-B mRNA expression in the larger neurons of the RGC layer decreased from day 3. On day 14, little or no detectable transcripts were demonstrated in these neuronal cells (Fig. 1f). 
Optic ner6e
The normal and sham operation optic nerves showed only weak immunostaining for PDGF-B in the interfascicular glial cells, vascular cells, and axons (Fig. 2a) . in situ hybridization histochemistry showed weak mRNA expression in some interfascicular glial cells and the vasculature, but not in the axons (Fig. 2b ). There were no histological differences in optic tissue among the sham operated animals, normal animals and the contralateral side of the transected animals.
From day 2 edematous and necrotic changes (injury: I area) were observed at the cut end of the transected optic nerves. These changes gradually increased in size as time progressed. In this area, RCA-1 positive cells were not observed, and GFAP-positive cells decreased in number for a few days. On day 5, some clumped RCA-1-positive cells were identified as macrophages due to their round swollen cytoplasm with foamy appearance. On day 7, a large number of macrophages were found to have accumulated not only in the I area, where the normal structure of the ON had disappeared, but also around the I area (Fig. 3a) . PDGF-B immunoreactivity was first found in some macrophages in the I area on day 5. These macrophages expressed intense PDGF-B mRNA from day 5. On day 7, the most intense and numerous expression of both PDGF-B protein and mRNA was observed in the perinuclear region of macrophages in this area (Fig. 3b) . This PDGF-B expression decreased after this and only a low level of expression was detected on day 14 ( Table 1) .
The part of ON between the site of injury (I) and the distal portion (D), was defined as the interface (IF) area. Small RCA-1-positive cells, probably microglial cells, and macrophages increased in number, predominantly in a closer part of IF area to I area, peaking from day 3 to 7 ( Fig. 4a) . GFAP-positive cells increased mainly at a more distal part of the IF area (Fig. 4b) . Throughout the IF area, an accumulation of PDGF-B immunoproducts was found in egg or oval shaped swollen axons between day 1 and 10, peaking on days 1 -3 (Fig. 5a) . However, PDGF-B mRNA was not localized in these degenerated axons. Both PDGF-B protein and mRNA were expressed in reactive glial cells in this area from day 2 to 14, peaking on day 3-7 ( Fig.  5a,b ). These cells with PDGF-B expression were distributed everywhere in the IF area, and the distribution did not agree with that of either the GFAP nor the RCA-1 positive cells (Fig. 4a,b,c) .
In the distal area (D) of the transected ON, GFAPpositive cells began to show enlarged cytoplasms and elongated processes from day 2 which increased in number after day 3. Small RCA-1-positive cells also appeared in this area, but they rarely showed metamorphosis to macrophages. On day 14, GFAP-positive cells showed a decrease in the number of their processes. In these areas, PDGF-B immunoreactivity was found in the interfascicular glial cells and vascular cells (Fig. 6a) . The number of glial cells with PDGF-B immunoreactivity increased on days 1-14, peaking on days 3-7. Interfascicular glial cells also showed an increased PDGF-B mRNA from day 1 (Fig. 6b) .
Analyses of serial sections from the animals on day 7 after transection revealed that in the D area the cells with PDGF-B immunoreactivity were GFAP-positive cells, whereas none of the RCA-1-positive cells showed PDGF-B immunoreactivity, as shown in Fig. 7a,b,c. 
Discussion
In the present study, concordant expression of PDGF-B protein and mRNA was detected in the soma of larger neurons, but not in that of smaller neurons of the RGC layer in intact rat retinas. These larger neurons with PDGF-B expression decreased in number after transection of the ON. It has been reported that larger and smaller neurons are present in the RGC layer [27, 28] , and that larger neurons decrease selectively in number after ON transection, whereas the smaller neurons remain intact [28, 29] . And, it is generally assumed that larger and smaller neurons corre- spond to RGCs and displaced amacrine cells, respectively. Therefore, we interpreted that the larger neurons which expressed PDGF-B were RGCs. In the literature, characterization of the PDGF-B-positive cells in the RGC layer is controversial. Mudhar et al. [30] regarded the PDGF-B mRNA-positive cells in the RGC layer of young mice as mature vascular cells, whereas Robbins et al. [22] reported in normal human retina that PDGF-B immunoreactivity was observed in Mü ller cell end-feet and in the vasculature. Our present study is the first to report the exact localization of PDGF-B in RGCs. In addition to the PDGF-B protein and mRNA expressed in the RGCs, the nerve fiber layer showed PDGF-B immunoreactivity, but did not express PDGF-B mRNA. The PDGF-B immunoreactivity in the RGCs and optic nerve fiber layer, however, disappeared after the ON transection. Thus, it is most probable that PDGF-B is produced in the RGCs and transported to the ON by axonal flow.
Our investigation revealed that PDGF-B protein and its mRNA signal in RGCs decreased after ON transection, and that RGCs became atrophic and disappeared with advancing days after transection. The decrease in PDGF-B expression mentioned above preceded the cell loss. These findings may suggest that the decrease in PDGF-B caused the retrograde degeneration of RGCs after ON transection. This hypothesis is supported by a study in which a decrease in PDGF-B immunoreactivity in axotomized vagal neurons resulted in degenerative changes followed by regenerative changes, whereas no remarkable changes were observed in axotomized hypoglossal neurons [31] .
Functional PDGF i-receptors have been observed in rat neuronal cells [20] . Phosphorylation of the PDGF i-receptor is reported to activate protein kinase C [32] which is abundant in the CNS and appears to be involved in several specialized functions such as longterm potentiation [33, 34] , neurotrophism [35, 36] and the release of neurotransmitters [37] . These results may suggest that the decrease in PDGF-B production in RGCs following ON transection causes degeneration and reduction of RGCs through metabolic disturbances in the cells.
Exogenous administration of growth factors, including FGF, NGF, BDNF and CNTF, has been reported to rescue some RGCs from retrograde degeneration following axotomy [5, 23, 38] . PDGF-B is thought to be an important endogenous neurotrophic factor for RGCs because it decreases after axotomy followed by cell death. PDGF-B may be one of the best candidate growth factors to be administered exogenously to protect RGCs from retrograde cell death after ON injury.
The first change in PDGF-B at the site of ON transection was the accumulation of PDGF-B protein in the swollen egg or oval shaped axons. This was followed by the accumulation of reactive cells such as astrocytes, macrophages and microglial cells. PDGF-B is known to be a potent mitogenic and chemoattractant factor for glial cells and mesenchymal cells [14, 15] , so rat PDGF-B derived from the swollen axons at the transection site seems to trigger the accumulation of the reactive cells. Numerous macrophages observed in the stump of the transected ON showed intensive PDGF-B expression between day 5 and 7 after ON transection.
We have also observed this macrophage response in our previous ischemic brain study [39] and cerebral stab wounds [40] . Macrophage-derived PDGF-B may further participate in stimulating the accumulation of glial cells [14, 15] . In support of this view, astrocytosis after stab wounds is dramatically suppressed by treatment with trapidil, a specific antagonist of PDGF [41] . Although we may suppose that increased PDGF-B expression in glial cells in the distal portion of ON plays a role in the subsequent cellular cascade of wallerian degeneration, the exact role of PDGF-B remains to be determined in the future.
In conclusion, from the present study, it is most probable that PDGF-B is produced in RGCs and transported to the ON. The decrease in PDGF-B in RGCs after ON transection seems to cause the loss of RGCs, suggesting that PDGF-B takes a part in the survival of RGCs. Increased PDGF-B expression in the stump of the ON may play a role in the cascade of tissue reaction in the ON following transection.
